Literature DB >> 6314491

Mechanisms of action of loperamide.

B K Sandhu, P J Milla, J T Harries.   

Abstract

The beneficial effect of loperamide in some children with severe protracted diarrhoea which persisted when nil by mouth, made us suspect that loperamide may have an antisecretory action. Using a steady-state perfusion technique in rat jejunum we showed that loperamide inhibits cholera toxin induced secretion of water, sodium and chloride (p less than 0.001). This antisecretory action was blocked by naloxone and not mediated via an effect on tissue cyclic AMP level or adenylate cyclase activity. More recently we have studied the effect of loperamide on secretion of water in the rat jejunum induced by other agents with differing mechanisms of action. The first set of observations suggest that loperamide's antisecretory effect is mediated via opiate receptors either distal to, or separate from the adenylate cyclase/cyclic AMP pathway. Our more recent studies support the notion that loperamide has an effect on specific transport systems rather than non-specific passive diffusional processes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6314491

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  4 in total

1.  Secretagogue-induced changes in membrane calcium permeability in chicken and chinchilla ileal mucosa. Selective inhibition by loperamide.

Authors:  E B Chang; D R Brown; N S Wang; M Field
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

Review 2.  Current management of acute diarrhoeas. Use and abuse of drug therapy.

Authors:  A C Ludan
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 3.  Protracted diarrhea in infancy.

Authors:  B K Sandhu; P J Milla
Journal:  Indian J Pediatr       Date:  1984 Jan-Feb       Impact factor: 1.967

4.  Loperamide inhibits gallbladder inflammatory fluid secretion in experimental cholecystitis.

Authors:  L Jivegård; J Svanvik
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-06       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.